HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis.

Abstract
Hemodialysis (HD) is associated with increasing thrombotic trend. Vascular access thrombosis (VAT) increases morbidity in HD patients. The aim of this study was to evaluate ADAMTS13 and VWF plasma levels from patients undergoing HD as putative biomarkers of the hypercoagulability state, as well the association between these markers and VAT occurrence. This study included 195 patients on HD for more than 6 months. HD patients were allocated into two groups according to the occurrence or not of previous episode of VAT; HD with VAT (N = 46) and HD without VAT (N = 149). ADAMTS13 and VWF were performed by ELISA. There was no significant difference between HD patients with and without VAT for ADAMTS13 and VWF levels. However, VWF levels were higher (P < 0.001) and ADAMTS13 were lower (P < 0.001) in HD patients, comparing to the control group composed by healthy subjects without kidney disease, age and sex-matched (N = 80). Taken together our data suggest a potential role of the kidneys function compromised on ADAMTS13 synthesis or metabolism, regardless other known sources of ADAMTS13. The imbalance between ADAMTS13 and VWF levels does not explain the development of VAT in HD patients by itself, although it should contribute for the hypercoagulability state. Therefore, additional studies to identify other risk factors are warranted and essential for better management of HD patients.
AuthorsDanyelle R A Rios, Maria G Carvalho, Roberta C Figueiredo, Cláudia N Ferreira, Valério L Rodrigues, Regina A Souza, Ana C Simões e Silva, Ana Paula Fernandes, Karina B Gomes, Luci M S Dusse
JournalJournal of thrombosis and thrombolysis (J Thromb Thrombolysis) Vol. 34 Issue 1 Pg. 73-8 (Jul 2012) ISSN: 1573-742X [Electronic] Netherlands
PMID22298244 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • von Willebrand Factor
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
Topics
  • ADAM Proteins (blood)
  • ADAMTS13 Protein
  • Adolescent
  • Adult
  • Aged
  • Biomarkers (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Kidney (metabolism)
  • Kidney Diseases (blood, therapy)
  • Male
  • Middle Aged
  • Renal Dialysis (adverse effects)
  • Thrombosis (blood, etiology)
  • Time Factors
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: